Trial Profile
A randomised, double-blind, placebo-controlled phase 2 trial of FOL-005 to investigate efficacy on hair growth on scalp skin in healthy volunteers
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Dec 2020
Price :
$35
*
At a glance
- Drugs FOL 005 (Primary)
- Indications Alopecia
- Focus Therapeutic Use
- Sponsors Follicum AB
- 31 Oct 2018 Primary endpoint (To evaluate the efficacy of FOL-005 on scalp hair density) has not been met, , according to a Follicum AB media release.
- 31 Oct 2018 Status changed from active, no longer recruiting to completed, according to a Follicum AB media release.
- 31 Oct 2018 Results presented in a Follicum AB media release.